HK1084977A1 - Streptococcus pyogenes antigens - Google Patents

Streptococcus pyogenes antigens

Info

Publication number
HK1084977A1
HK1084977A1 HK06107447.8A HK06107447A HK1084977A1 HK 1084977 A1 HK1084977 A1 HK 1084977A1 HK 06107447 A HK06107447 A HK 06107447A HK 1084977 A1 HK1084977 A1 HK 1084977A1
Authority
HK
Hong Kong
Prior art keywords
antigens
streptococcus pyogenes
pyogenes antigens
hyperimmune serum
serum reactive
Prior art date
Application number
HK06107447.8A
Other languages
English (en)
Inventor
Andreas Meinke
Eszter Nagy
Birgit Winkler
Dieter Gelbmann
Original Assignee
Intercell Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intercell Ag filed Critical Intercell Ag
Publication of HK1084977A1 publication Critical patent/HK1084977A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK06107447.8A 2003-03-04 2006-06-30 Streptococcus pyogenes antigens HK1084977A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03450061 2003-03-04
PCT/EP2004/002087 WO2004078907A2 (en) 2003-03-04 2004-03-02 Streptococcus pyogenes antigens

Publications (1)

Publication Number Publication Date
HK1084977A1 true HK1084977A1 (en) 2006-08-11

Family

ID=32946995

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06107447.8A HK1084977A1 (en) 2003-03-04 2006-06-30 Streptococcus pyogenes antigens

Country Status (16)

Country Link
US (3) US7638136B2 (de)
EP (8) EP2287315A1 (de)
JP (2) JP2006520202A (de)
CN (2) CN102512670A (de)
AT (1) ATE441715T1 (de)
AU (2) AU2004218284B2 (de)
CA (1) CA2517518A1 (de)
CY (1) CY1109683T1 (de)
DE (1) DE602004022923D1 (de)
DK (1) DK1601770T3 (de)
ES (1) ES2330334T3 (de)
HK (1) HK1084977A1 (de)
PL (1) PL1601770T3 (de)
PT (1) PT1601770E (de)
SI (1) SI1601770T1 (de)
WO (1) WO2004078907A2 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7939087B2 (en) * 2000-10-27 2011-05-10 Novartis Vaccines And Diagnostics, Inc. Nucleic acids and proteins from Streptococcus groups A & B
CA2438921C (en) 2001-02-21 2012-04-10 Shire Biochem Inc. Streptococcus pyogenes polypeptides and corresponding dna fragments
AU2003260102A1 (en) * 2002-08-26 2004-03-11 Chiron Corporation Conserved and specific streptococcal genomes
PT1648500E (pt) * 2003-07-31 2014-10-10 Novartis Vaccines & Diagnostic Composições imunogénicas para estreptococos piogenes
ITRM20030376A1 (it) 2003-07-31 2005-02-01 Univ Roma Procedimento per l'isolamento e l'espansione di cellule staminali cardiache da biopsia.
US8945589B2 (en) 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
CA2575548A1 (en) 2004-07-29 2006-07-27 John L. Telford Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
EP1807446A2 (de) * 2004-10-08 2007-07-18 Novartis Vaccines and Diagnostics, Inc. Immunogene und therapeutische zusammensetzungen für pyogene streptokokken
US11660317B2 (en) 2004-11-08 2023-05-30 The Johns Hopkins University Compositions comprising cardiosphere-derived cells for use in cell therapy
CA2612394C (en) 2005-06-15 2017-02-21 The Ohio State University Research Foundation Her-2 peptides
CA2961849C (en) * 2005-08-26 2022-08-02 Dupont Nutrition Biosciences Aps Use of crispr associated genes (cas)
US20100015168A1 (en) * 2006-06-09 2010-01-21 Novartis Ag Immunogenic compositions for streptococcus agalactiae
EP2287189A1 (de) 2006-07-07 2011-02-23 Intercell AG Kleine Streptococcus pyogenes Antigene und die Verwendung davon
JP2010508276A (ja) * 2006-10-30 2010-03-18 ノバルティス アーゲー 化膿連鎖球菌のための免疫原性組成物および治療組成物
BRPI0604997A (pt) 2006-11-30 2007-05-22 Fundacao Zerbini vacina contra o estreptococo beta hemolìtico do grupo a, e respectivo processo de obtenção
GB0624874D0 (en) * 2006-12-13 2007-01-24 Hansa Medical Ab Treatment
EP2503008B1 (de) 2007-04-19 2015-04-01 Molecular Detection Inc. Verfahren, Zusammensetzungen und Kits zur Erkennung und Analyse von Antibiotika-resistenten Bakterien
EP2173902A4 (de) * 2007-07-03 2013-01-09 Mt Sinai Hospital Therapeutika und diagnostika für gruppe-a-streptokokken
BRPI0816689B1 (pt) * 2007-09-12 2021-08-24 Novartis Ag Composição de vacina, kit e método para a confecção de uma composição de vacina para a prevenção ou tratamento de infecção por streptococcus pyogenes
AU2013203022B2 (en) * 2007-09-12 2015-09-03 Glaxosmithkline Biologicals S.A. GAS57 mutant antigens and GAS57 antibodies
CA2709927C (en) 2007-12-21 2017-05-16 Novartis Ag Mutant forms of streptolysin o
EP2650015A2 (de) * 2008-06-20 2013-10-16 Wyeth LLC Zusammensetzungen und Verfahren zur Verwendung von ORF 554 von Beta-Hämolytischen Streptokokken-Stämmen
RU2478396C2 (ru) * 2008-11-05 2013-04-10 ВАЙЕТ ЭлЭлСи МНОГОКОМПОНЕНТНАЯ ИММУНОГЕННАЯ КОМПОЗИЦИЯ ДЛЯ ПРЕДУПРЕЖДЕНИЯ ЗАБОЛЕВАНИЯ, ВЫЗВАННОГО β-ГЕМОЛИТИЧЕСКИМИ СТРЕПТОКОККАМИ (БГС)
US20100234283A1 (en) 2009-02-04 2010-09-16 The Ohio State University Research Foundation Immunogenic epitopes, peptidomimetics, and anti-peptide antibodies, and methods of their use
GB0918392D0 (en) * 2009-10-20 2009-12-02 Novartis Ag Diagnostic and therapeutic methods
WO2013166281A1 (en) * 2012-05-02 2013-11-07 Cedars-Sinai Medical Center Bi-functional compositions for targeting cells to diseased tissues and methods of using same
US9845457B2 (en) 2010-04-30 2017-12-19 Cedars-Sinai Medical Center Maintenance of genomic stability in cultured stem cells
US9249392B2 (en) 2010-04-30 2016-02-02 Cedars-Sinai Medical Center Methods and compositions for maintaining genomic stability in cultured stem cells
EP2861238A4 (de) 2012-06-05 2016-03-16 Capricor Inc Optimierte verfahren zur erzeugung von herzstammzellen aus herzgewebe und deren verwendung in der herztherapie
EP2882445B1 (de) 2012-08-13 2019-04-24 Cedars-Sinai Medical Center Exosomen und mikroribonukleinsäuren zur geweberegeneration
EP2953641A4 (de) * 2013-02-11 2016-11-16 Univ Tennessee Res Foundation Gruppe-a-streptokokken-m-verwandte proteine und verfahren zur verwendung
US11357799B2 (en) 2014-10-03 2022-06-14 Cedars-Sinai Medical Center Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy
GB201502306D0 (en) * 2015-02-12 2015-04-01 Hansa Medical Ab Protein
US10329601B2 (en) * 2015-12-28 2019-06-25 Ionian Technologies, Inc. Nicking and extension amplification reaction (NEAR) of Streptococcus species
EP3402543B1 (de) 2016-01-11 2021-09-08 Cedars-Sinai Medical Center Aus kardiosphäre stammende zellen und durch solche zellen sekretierte exosomen in der behandlung von herzversagen mit konservierter auswurffraktion
US11351200B2 (en) 2016-06-03 2022-06-07 Cedars-Sinai Medical Center CDC-derived exosomes for treatment of ventricular tachyarrythmias
WO2018057542A1 (en) 2016-09-20 2018-03-29 Cedars-Sinai Medical Center Cardiosphere-derived cells and their extracellular vesicles to retard or reverse aging and age-related disorders
EP3612191A4 (de) 2017-04-19 2020-12-30 Cedars-Sinai Medical Center Verfahren und zusammensetzungen zur behandlung von skelettmuskeldystrophie
CA3061727A1 (en) * 2017-04-26 2018-11-01 Auckland Uniservices Limited Analytical and therapeutic methods and compositions, and uses thereof
US11660355B2 (en) 2017-12-20 2023-05-30 Cedars-Sinai Medical Center Engineered extracellular vesicles for enhanced tissue delivery
JP2020117470A (ja) * 2019-01-25 2020-08-06 公益財団法人ヒューマンサイエンス振興財団 抗体並びに劇症型溶血性レンサ球菌感染症を予防及び／又は治療するための薬剤
CN110438261B (zh) * 2019-07-29 2022-08-12 华南农业大学 用于检测f亚群禽白血病病毒的分子标记、引物、试剂盒及应用
EP4377329A1 (de) * 2021-07-29 2024-06-05 Université de Lausanne Neuartige pneumokokken-polypeptidantigene
CN117417427B (zh) * 2023-09-11 2024-05-07 江苏省人民医院（南京医科大学第一附属医院） 一种检测内源性自体胰岛素介导的胰岛素抗体的试剂盒

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB234771A (en) * 1924-06-02 1926-02-11 S T Leigh And Company Ltd Improved means for inserting cork discs, or the like, into caps or covers
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5475096A (en) 1990-06-11 1995-12-12 University Research Corporation Nucleic acid ligands
DE59109269D1 (de) 1990-06-28 2005-12-15 Hoechst Ag Fusionsproteine mit Immunglobulinanteilen, ihre Herstellung und Verwendung
RO117329B1 (ro) * 1991-06-24 2002-01-30 Chiron Corp Emeryville Polipeptide care contin o secventa a virusului hepatitei c
ATE420171T1 (de) 1994-07-15 2009-01-15 Univ Iowa Res Found Immunomodulatorische oligonukleotide
CN1192241A (zh) * 1995-06-07 1998-09-02 生化疫苗公司 Hsp70家族的链球菌热休克蛋白
RS50101B (sr) 1996-02-24 2009-01-22 Boehringer Ingelheim International Gmbh., Farmaceutski preparati za imunomodulaciju
ATE228529T1 (de) 1996-08-30 2002-12-15 Jens Peter Fuerste Spiegelselektion und spiegelevolution von nucleinsäuren
US5849902A (en) 1996-09-26 1998-12-15 Oligos Etc. Inc. Three component chimeric antisense oligonucleotides
US5989912A (en) 1996-11-21 1999-11-23 Oligos Etc. Inc. Three component chimeric antisense oligonucleotides
JP3515314B2 (ja) * 1997-03-25 2004-04-05 扶桑薬品工業株式会社 ストレプトコッカス・ピオゲネス菌に起因する感染症の診断用プローブ
DE19742706B4 (de) 1997-09-26 2013-07-25 Pieris Proteolab Ag Lipocalinmuteine
DE19803453A1 (de) 1998-01-30 1999-08-12 Boehringer Ingelheim Int Vakzine
TR200200633T2 (tr) 1998-12-23 2002-06-21 Shire Biochem Inc. Yeni streptococcus antijenleri
AT408721B (de) 1999-10-01 2002-02-25 Cistem Biotechnologies Gmbh Pharmazeutische zusammensetzung enthaltend ein antigen
CA2396040A1 (en) 1999-12-30 2001-07-12 Bristol-Myers Squibb Company Novel bacterial genes and proteins that are essential for cell viability and their uses
AT409085B (de) 2000-01-28 2002-05-27 Cistem Biotechnologies Gmbh Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen
DE60130877T2 (de) 2000-04-14 2008-07-17 Intercell Ag Modifizierte peptide enthaltende pharmazeutische präparationen
AT410173B (de) 2000-06-08 2003-02-25 Cistem Biotechnologies Gmbh Antigene zusammensetzung
IL152959A0 (en) 2000-06-08 2003-06-24 Intercell Biomedizinische Forschungs & Entwicklungs Gmbh Immunostimulatory oligodeoxynucleotides
AU2000279060A1 (en) 2000-07-10 2002-01-21 Telefonaktiebolaget Lm Ericsson (Publ) Resource management in uncoordinated frequency hopping system
AU8981301A (en) 2000-08-17 2002-02-25 Cistem Biotechologies Gmbh A vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide or a derivative thereof
AT410635B (de) 2000-10-18 2003-06-25 Cistem Biotechnologies Gmbh Vakzin-zusammensetzung
US7939087B2 (en) * 2000-10-27 2011-05-10 Novartis Vaccines And Diagnostics, Inc. Nucleic acids and proteins from Streptococcus groups A & B
AT410798B (de) 2001-01-26 2003-07-25 Cistem Biotechnologies Gmbh Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
CA2438921C (en) * 2001-02-21 2012-04-10 Shire Biochem Inc. Streptococcus pyogenes polypeptides and corresponding dna fragments
AU2002306849A1 (en) * 2001-03-21 2002-10-08 Elitra Pharmaceuticals, Inc. Identification of essential genes in microorganisms
GB0107658D0 (en) * 2001-03-27 2001-05-16 Chiron Spa Streptococcus pneumoniae
IL158328A0 (en) * 2001-04-13 2004-05-12 Wyeth Corp Surface proteins of streptococcus pyogenes
EP2261241A1 (de) 2001-04-16 2010-12-15 Wyeth Holdings Corporation Polypeptidantigene codierende offene leseraster aus streptococcus pneumoniae und verwendungen davon
FR2824074A1 (fr) * 2001-04-26 2002-10-31 Pasteur Institut Sequence du genome streptococcus agalactiae, application au developpement de vaccins, d'outils de diagnostic, et a l'identification de cibles therapeutiques
GB0210128D0 (en) * 2002-05-02 2002-06-12 Chiron Spa Nucleic acids and proteins from streptococcus groups A & B
NZ540731A (en) * 2002-12-20 2008-04-30 Univ New Jersey Med Compositions and methods for enzymatic detachment of bacterial and fungal biofilms
PT1648500E (pt) * 2003-07-31 2014-10-10 Novartis Vaccines & Diagnostic Composições imunogénicas para estreptococos piogenes
EP2287189A1 (de) * 2006-07-07 2011-02-23 Intercell AG Kleine Streptococcus pyogenes Antigene und die Verwendung davon
EP2045869A1 (de) 2007-10-02 2009-04-08 Rohde & Schwarz GmbH & Co. KG Richtkoppler

Also Published As

Publication number Publication date
ATE441715T1 (de) 2009-09-15
AU2004218284B2 (en) 2009-07-23
DE602004022923D1 (de) 2009-10-15
EP2053125A1 (de) 2009-04-29
WO2004078907A3 (en) 2005-03-10
CN1756843A (zh) 2006-04-05
EP2287311A1 (de) 2011-02-23
PT1601770E (pt) 2009-12-07
AU2009230772A1 (en) 2009-11-26
EP2053125B1 (de) 2014-04-30
US20060194751A1 (en) 2006-08-31
AU2004218284A1 (en) 2004-09-16
AU2009230772B2 (en) 2013-07-18
EP2287312A1 (de) 2011-02-23
CA2517518A1 (en) 2004-09-16
EP1601770B1 (de) 2009-09-02
EP2287315A1 (de) 2011-02-23
JP2006520202A (ja) 2006-09-07
EP2287313A1 (de) 2011-02-23
CY1109683T1 (el) 2014-08-13
JP2011015689A (ja) 2011-01-27
SI1601770T1 (sl) 2010-01-29
US20100255034A1 (en) 2010-10-07
US8349336B2 (en) 2013-01-08
CN1756843B (zh) 2012-03-21
EP2290082A1 (de) 2011-03-02
ES2330334T3 (es) 2009-12-09
EP1601770A2 (de) 2005-12-07
WO2004078907A2 (en) 2004-09-16
US20130122047A1 (en) 2013-05-16
US7638136B2 (en) 2009-12-29
CN102512670A (zh) 2012-06-27
PL1601770T3 (pl) 2010-02-26
EP2287314A1 (de) 2011-02-23
DK1601770T3 (da) 2009-11-02

Similar Documents

Publication Publication Date Title
HK1084977A1 (en) Streptococcus pyogenes antigens
WO2004092209A3 (en) S. pneumoniae antigens
WO2005103073A3 (en) Td antigens
WO2004099242A3 (en) Streptococcus agalactiae antigens i + ii
WO2002062850A3 (en) Hybrid antibodies and uses thereof
IL188094A0 (en) Il-1?? binding antibodies and fragments thereof
IN2009KN02655A (de)
MXPA05014016A (es) Proteinas portadoras para vacunas.
WO2004106367A3 (en) Enterococcus antigens
WO2003050243A3 (en) Novel genes encoding colon cancer antigens
IL169804A (en) 254p1d6b proteins, nucleic acids encoding the same, processes for producing the same, antibodies binding thereto and uses thereof
UA94206C2 (ru) Бактериальные факторы вирулентности и варианты их применения
WO2002075274A3 (fr) Methode et trousse pour le suivi des maladies neurodegeneratives
WO2004094467A3 (en) H. pylori antigens
ATE449177T1 (de) Staphylococcus epidermidis antigene
WO2000050607A3 (en) Goodpasture antigen binding protein
DE602004018155D1 (de) Einen grössenausschlussschritt verwendendes verbessertes bisulfit-verfahren
WO2001066752A3 (en) Reproduction-specific genes
WO2004113374A3 (en) Chlamydia pneumoniae antigens
WO2005051985A3 (en) Methods for purifying pertussis toxin and peptides useful therefor
WO2002066650A3 (en) Streptococcus pyogenes polypeptides and corresponding dna fragments
WO2003022992A3 (en) Mammalian genes; related reagents
WO2005000882A3 (en) Dna fragments and proteins encoded by said dna isolated from bifidobacteria
WO2002022807A3 (en) Dermatophagoides nucleic acid molecules, proteins and uses thereof
WO2001021794A3 (en) Smad associating polypeptides

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20160302